Press release - Change in management at Hirslanden Klinik Beau-Site
PDF | 210.34 KB
Daniela de la Cruz, Hospital Manager of Hirslanden Klinik Beau-Site in Bern has been appointed CEO of the Swiss Cancer League. She will leave the hospital at the end of September.
Daniela de la Cruz has been working for the Hirslanden Private Hospital Group since 2015, initially as Hospital Manager of Klinik Birshof in Münchenstein Basel and since 2017 as Hospital Manager of Klinik Beau-Site in Bern.
Under de la Cruz’s leadership, Klinik Birshof in the Basel region established itself as a first-class provider of medical care specialising in the musculoskeletal system. The range of spinal surgery procedures was expanded, and ear, nose and throat (ENT) services were added to the hospital’s specialisations.
Under the leadership of Daniela de la Cruz, Klinik Beau-Site in Bern positioned itself as a cross-regional centre for specialised and highly specialised medicine. Among other projects, the hospital entered into pioneering cardiac surgery cooperation with Inselspital. In this way the hospital is making an essential contribution to providing healthcare for the people in the Bern region. Together with Hirslanden Salem-Spital, Hirslanden Klinik Permanence and Hirslanden Klinik Linde it is an important cog in the tiered healthcare model pursued by the Hirslanden hospitals in Bern.
The Executive Committee of the Hirslanden Private Hospital Group would like to warmly thank Daniela de la Cruz for her dedicated commitment and great achievements in the past few years and wishes her all the best and every success for this new challenge.
The search for a new Hospital Manager for Klinik Beau-Site is already under way.
The Hirslanden Private Hospital Group consists of 18 hospitals in 11 cantons, many of which have an outpatient surgery centre and emergency department. The Group also operates 4 outpatient clinics, 17 radiology institutes and 5 radiotherapy institutes. As of 31 March 2018, the group had around 1,680 affiliated doctors and 9,635 employees, of whom 461 were permanently employed doctors. Hirslanden is the leading private hospital group and the largest medical network in Switzerland. In the 2017/18 financial year, the group generated turnover of 1,735 million Swiss francs. Between 01.01.2018 and 31.03.2018 the group treated more than 102,903 patients, amounting to a total of 473,343 inpatient days. In insurance terms, the patient mix consists of 47.9% basic, 29.7% semi-private, and 22.4% private insured patients.
The Hirslanden Private Hospital Group is synonymous with first-class medical care provided by highly qualified medical specialists with years of experience. As a system provider, Hirslanden stands out from the rest of the market: interdisciplinary medical centres of expertise and specialised institutes enable it to offer the best possible individualised treatment, even in highly complex cases. The Hirslanden Private Hospital Group was formed in 1990 through the merger of several Swiss private hospitals. Since 2007 it has been part of the international hospital group Mediclinic International plc, which is listed on the London Stock Exchange.